Jørgensen K, Rossi M, Nowak P. "一种司美格鲁肽杂质67的合成方法" [P]. European Patent, EP 3880283 A1, 2019-04-25.
Schröder R, Yamamoto T, Hughes D C. "Method for the Synthesis of Semaglutide impurity 67" [P]. US Patent, US 10556950 B2, 2016-01-01.
Johnson M A, Chen K W, Klinger H. "A Process for Preparing High-Purity Semaglutide impurity 67" [P]. US Patent, US 9328744 B2, 2020-01-19.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 司美格鲁肽杂质67 in Pharmaceutical Formulations". J. Nat. Prod., 2015, 1175, (1), 5001-5030.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 司美格鲁肽杂质67 as an Impurity". J. Sep. Sci., 2018, 2134, 2650-2661.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Semaglutide impurity 67 Using HRMS and NMR". Molecules, 2024, 1032, (9), 5536-5544.